Diplomat to Dispense AstraZeneca Drug IRESSA®

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Diplomat to Dispense AstraZeneca Drug IRESSA®

Diplomat Pharmacy (DPLO) Will Begin Offering IRESSA (AZN)

August 10, 2015 5:09 PM EDT

Diplomat Pharmacy (NYSE: DPLO) announced that it will offer IRESSA (gefitinib), recently approved by the U.S. Food and Drug Administration as a first-line therapy for a specific type of metastatic non-small cell lung cancer (NSCLC).

IRESSA is a once-daily oral medication that targets and blocks the activity of epidermal growth factor receptor-tyrosine kinase (EGFR-TK), an enzyme that regulates the intracellular signaling... More